Efficacy of Methylprednisolone for Pain Control After ACL Repair

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-21

Study Completion Date

2031-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Opioids are commonly used after orthopedic surgery for pain control but have been shown to increase complications, surgeries, readmissions, and risk for opioid use disorder. The purpose of this study is to investigate the impact of adding a methylprednisolone taper to the pain regimen after ACL repair surgery to determine if this results in decreased postoperative pain and opioid use without increasing complications.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Large Doses of Methylprednisolone Combined With Gabapentin in Total Knee Arthroplasty

NCT04653415

Arthroplasty Complications Knee Osteoarthritis Pain, Postoperative +1 more

COMPLETED PHASE4

Medrol Dosepak for Outpatient Total Knee Arthroplasty

NCT05097976

Total Knee Arthroplasty

RECRUITING PHASE4

The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty

NCT04003350

Osteo Arthritis Knee

COMPLETED NA

Oral Melatonin With Intra Articular Analgesia on Pain After Arthroscopic Anterior Cruciate Ligament Reconstruction

NCT07096635

Pain Relief After Arthroscopic Anterior Cruciate Ligament Reconstruction

NOT_YET_RECRUITING NA

Periarticular Injection and Hamstring Block Versus Placebo for Pain Control in Anterior Cruciate Ligament Reconstruction

NCT05248724

Anterior Cruciate Ligament Reconstruction

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is to include consecutive patients who undergo ACL repair by fellowship trained surgeons at a single institution with minimum 12 week follow up. All patients between the ages of 13-50 who are willing and able to provide informed consent will be included. Patients will be assessed preoperatively and then at 2 weeks, 6 weeks,12 weeks, and 1 year clinic visits, which is standard of care. The patient will fill out 2 questions on the MyCap app the day of surgery and for 14 days following surgery for pain scores and 15 days for amount of opioid pills consumed the day prior. Patient demographic, comorbidity, and surgical data will be collected from the medical record, including age, sex, BMI, smoking status, and diabetic status.

Patients will be randomized to the treatment or control group. The treatment group will receive the following pain regimen after surgery: Medrol dose pack, Meloxicam, Hydrocodone/Acetaminophen, and Gabapentin. The control group will be prescribed: Ketoralac, Hydrocodone/Acetaminophen, and Gabapentin. Pain reporting and opioid consumption will be assessed via the MyCap app for two weeks following surgery.

Patients will be followed at standard of care clinic appointments for 1 year. PROMs data will be collected at that time, in addition to any complications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ACL Surgery Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Medrol group

Patients will receive Medrol dose pack, Meloxicam, Hydrocodone/Acetaminophen, and Gabapentin as pain regimen upon discharge from surgery.

Group Type ACTIVE_COMPARATOR

Meloxicam 15 mg

Intervention Type DRUG

PO once/day for 1 week

Medrol 4 MG Oral Tablet Includes Medrol Dosepak

Intervention Type DRUG

PO 6 day taper

Gabapentin 300 mg

Intervention Type DRUG

PO every 8 hours for 1 week

Hydrocodone 5Mg/Acetaminophen 325Mg Tab

Intervention Type DRUG

PO 1-2 tabs every 4 hours as needed (total of 28 pills)

No Medrol group

Patients will receive Ketorolac, Hydrocodone/Acetaminophen, and Gabapentin as pain regimen upon discharge from surgery.

Group Type ACTIVE_COMPARATOR

Gabapentin 300 mg

Intervention Type DRUG

PO every 8 hours for 1 week

Hydrocodone 5Mg/Acetaminophen 325Mg Tab

Intervention Type DRUG

PO 1-2 tabs every 4 hours as needed (total of 28 pills)

Ketorolac 10 Mg Oral Tablet

Intervention Type DRUG

PO every 6 hours for 5 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Meloxicam 15 mg

PO once/day for 1 week

Intervention Type DRUG

Medrol 4 MG Oral Tablet Includes Medrol Dosepak

PO 6 day taper

Intervention Type DRUG

Gabapentin 300 mg

PO every 8 hours for 1 week

Intervention Type DRUG

Hydrocodone 5Mg/Acetaminophen 325Mg Tab

PO 1-2 tabs every 4 hours as needed (total of 28 pills)

Intervention Type DRUG

Ketorolac 10 Mg Oral Tablet

PO every 6 hours for 5 days

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient undergoing ACL repair or ACL reconstruction with tendon autograft
* Age 13-50 years old
* Able to provide informed consent or parent/legal guardian is able for minors

Exclusion Criteria

* Concurrent and significant injury to other bones or organs (Injury Severity Score of 4 or greater)
* Revision ACL reconstruction
* Concomitant additional ligament reconstruction or high tibial osteotomy
* A history of alcohol abuse, substance abuse or chronic opioid use (filled opioid medication ×2 within 6 months of the surgery)
* A history of renal failure (\<60 mL/min/1.73 m2), liver dysfunction (child class, \>B), severe heart disease (NYHA Class 4), diabetes, neurological or psychiatric diseases that may affect pain perception, and pre-existing immune suppression.
* A history or active peptic ulcer disease, gastrointestinal bleeding, or current use of anticoagulation.
* Patients currently taking oral or injectable glucocorticoids and those who have taken either within 1 month of the procedure.
* Patients who are currently pregnant.
* Patients who are unable to undergo the multimodal pain standardized protocol including those with comorbidities or medical allergies precluding the use of corticosteroids, gabapentin, hydrocodone, acetaminophen, ketorolac, and/or meloxicam.

Minimum Eligible Age

13 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No